Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis

Cell Death Dis. 2021 Mar 12;12(3):263. doi: 10.1038/s41419-021-03527-9.

Abstract

The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-CoV-2 cellular cytopathic effects requires definition. We performed a comparative ultrastructural study of SARS-CoV-1 and SARS-CoV-2 infection in Vero E6 cells and in lungs from deceased COVID-19 patients. SARS-CoV-2 induces rapid death associated with profound ultrastructural changes in Vero cells. Type II pneumocytes in lung tissue showed prominent altered features with numerous vacuoles and swollen mitochondria with presence of abundant lipid droplets. The accumulation of lipids was the most striking finding we observed in SARS-CoV-2 infected cells, both in vitro and in the lungs of patients, suggesting that lipids can be involved in SARS-CoV-2 pathogenesis. Considering that in most cases, COVID-19 patients show alteration of blood cholesterol and lipoprotein homeostasis, our findings highlight a peculiar important topic that can suggest new approaches for pharmacological treatment to contrast the pathogenicity of SARS-CoV-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COVID-19* / metabolism
  • COVID-19* / pathology
  • Chlorocebus aethiops
  • Cytopathogenic Effect, Viral
  • Humans
  • Lipid Droplets* / ultrastructure
  • Lipid Droplets* / virology
  • Lipid Metabolism*
  • Lung* / metabolism
  • Lung* / ultrastructure
  • Lung* / virology
  • SARS-CoV-2 / metabolism*
  • SARS-CoV-2 / ultrastructure
  • Severe Acute Respiratory Syndrome / metabolism
  • Severe Acute Respiratory Syndrome / pathology
  • Severe acute respiratory syndrome-related coronavirus / metabolism
  • Severe acute respiratory syndrome-related coronavirus / ultrastructure
  • Vero Cells